Position in GSK
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$49,622,659
-$6,086,182 QoQ
Shares Held
946,636
-6.2% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
0.74%
of 13F equity value
Holder Rank
#45
of 1,033 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 2%
Shared 0%
None 98%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Douglas Lane & Associates, LLC holds $414,684,195 across 11 Drug Manufacturers - General names. GSK ranks #4 (12.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
663,667 | $168,551,507 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
1,556,184 | $89,667,322 | |
| 3 | MRK |
Merck & Co., Inc.
|
552,155 | $70,951,917 | |
| 4 | GSK |
GSK plc
This page
|
946,636 | $49,622,659 | |
| 5 | NVS |
Novartis AG
|
140,152 | $21,964,621 | |
| 6 | AMGN |
Amgen Inc
|
13,032 | $4,719,147 | |
| 7 | LLY |
ELI LILLY & Co
|
2,861 | $3,431,569 | |
| 8 | ABBV |
AbbVie Inc.
|
9,961 | $2,506,586 |
All Filings in GSK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $49,622,659 | 946,636 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $55,708,841 | 1,009,401 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $51,236,501 | 1,044,790 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $48,378,000 | 1,120,899 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $50,576,985 | 1,317,109 | Shares | Sole | 2025-07-07 | |
| 2025-03-31 | $58,943,917 | 1,521,526 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $55,076,005 | 1,628,504 | Shares | Sole | 2025-01-08 | |
| 2024-09-30 | $88,851,985 | 2,173,483 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $85,023,785 | 2,208,410 | Shares | Sole | 2024-07-08 | |
| 2024-03-31 | $95,195,021 | 2,220,551 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $82,872,237 | 2,236,164 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $83,806,048 | 2,311,891 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $79,266,995 | 2,224,102 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $76,934,278 | 2,162,290 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $72,180,968 | 2,054,097 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $46,780,721 | 1,589,559 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $78,473,478 | 1,838,035 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $76,658,144 | 1,794,279 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $75,357,897 | 1,742,247 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $61,771,885 | 1,648,289 | Shares | Sole | 2021-10-21 | |
| 2021-06-30 | $57,860,462 | 1,481,495 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $47,047,121 | 1,344,021 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $42,108,772 | 1,166,660 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $40,174,268 | 1,088,223 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $37,845,302 | 945,971 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $32,108,633 | 864,006 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||